Patient and physician factors driving the gaps in use of drugs with cardiovascular and kidney benefits by medicare beneficiaries with type 2 diabetes treated by endocrinologists, nephrologists, and cardiologists: Population-based cohort study
{{output}}
Aims: Endocrinologists, nephrologists, and cardiologists care for people with type 2 diabetes (T2D) and coexisting cardiovascular disease (CVD), heart failure (HF), and/or chronic kidney disease (CKD). Glucagon-like peptide-1 rec... ...
